×
ADVERTISEMENT

afamitresgene autoleucel

FDA Grants Accelerated Approval to Tecelra for Unresectable or Metastatic Synovial Sarcoma

The FDA has granted accelerated approval to afamitresgene autoleucel (Tecelra, Adaptimmune LLC), a ...

AUGUST 2, 2024

Load more